Six-minute walk test desaturation and echocardiographic findings in IPF: Correlational observations made in the European IPF registry (eurIPFreg)

A. Guenther, F. Drakopanagiotakis, C. Vancheri, P. Bonniaud, A. Wells, B. Crestani (Giessen, Germany; Catania, Italy; Dijon, Paris, France; London, United Kingdom)

Source: International Congress 2014 – ILDs 2
Session: ILDs 2
Session type: Thematic Poster Session
Number: 761
Disease area: Interstitial lung diseases, Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Guenther, F. Drakopanagiotakis, C. Vancheri, P. Bonniaud, A. Wells, B. Crestani (Giessen, Germany; Catania, Italy; Dijon, Paris, France; London, United Kingdom). Six-minute walk test desaturation and echocardiographic findings in IPF: Correlational observations made in the European IPF registry (eurIPFreg). Eur Respir J 2014; 44: Suppl. 58, 761

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
6MWT performance by means of Spiropalm in patients affected by fibrotic idiopathic interstitial pneumonias: Preliminary observations
Source: International Congress 2014 – ILDs 6
Year: 2014


Clinical data, lung function and cardiopulmonary exercise testing in CPFE (combined pulmonary fibrosis with emphysema). Results of a cohort of 20 patients
Source: International Congress 2014 – ILDs 6
Year: 2014

Correlation between pulmonary function tests and HRCT indexes in Idiopathic Pulmonary Fibrosis (IPF) patients
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018

Long term efficacy of pirfenidone therapy in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2014 – ILDs 3
Year: 2014


Disease progression in IPF assessed using pulmonary function tests and functional respiratory imaging (FRI) – A pilot study
Source: International Congress 2014 – COPD and PAH related imaging
Year: 2014


Pirfenidone in idiopathic pulmonary fibrosis - description of a German cohort
Source: International Congress 2014 – ILDs 4
Year: 2014


Idiopathic pulmonary fibrosis is associated with a preferential alteration of kCO rather than of DLCO
Source: International Congress 2014 – ILDs 6
Year: 2014


Comparison of physiological impairment in ILD patients with and without diagnostic IPF features
Source: International Congress 2014 – ILDs 4
Year: 2014


The six minute walking test: Clinical predictors of survival in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity
Year: 2013


Clinical predictors of pulmonary hypertension in sarcoidosis
Source: Eur Respir J 2008; 32: 296-302
Year: 2008



Effect of design modifications on trial outcomes in idiopathic pulmonary fibrosis (IPF): Analysis of data from ASCEND and CAPACITY (CAP)
Source: International Congress 2014 – IPF and surroundings
Year: 2014


Intraindividual response to treatment with pirfenidone in two independent European IPF cohorts
Source: International Congress 2014 – ILDs 2
Year: 2014

Pulmonary distribution and localization of pirfenidone in animal models of IPF by MS/MS
Source: International Congress 2014 – ILDs 4
Year: 2014

Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis: Comparison with COPD
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions
Year: 2013

Prognostic significance of selected biomarkers in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease
Source: International Congress 2014 – Sarcoidosis
Year: 2014


Familial pulmonary fibrosis: Respiratory function progression analysis in different HRCT patterns
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015


Pulmonary hypertension in idiopathic pulmonary fibrosis: Utility of HRCT
Source: International Congress 2014 – COPD and PAH related imaging
Year: 2014

IPFdatabase – A new tool for a correct application of idiopathic pulmonary fibrosis guidelines
Source: International Congress 2014 – ILDs 2
Year: 2014

Pulmonary hemodynamics and lung function in patients with COPD and DPLD
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

Assessment of telomere length in the combined pulmonary fibrosis and emphysema syndrome
Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations
Year: 2014